{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:21:38Z","timestamp":1790709698852,"version":"4.1.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0009863","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T00:00:00Z","timestamp":1635120000000}}],"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cutaneous leishmaniasis (CL) is frequent in travellers and can involve oro-nasal mucosae. Clinical presentation impacts therapeutic management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>\n                      Demographic and clinical data from 459 travellers infected in 47 different countries were collected by members of the European LeishMan consortium. The infecting\n                      <jats:italic>Leishmania<\/jats:italic>\n                      species was identified in 198 patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Principal findings<\/jats:title>\n                    <jats:p>\n                      Compared to Old World CL, New World CL was more frequently ulcerative (75% vs 47%), larger (3 vs 2cm), less frequently facial (17% vs 38%) and less frequently associated with mucosal involvement (2.7% vs 5.3%). Patients with mucosal lesions were older (58 vs 30 years) and more frequently immunocompromised (37% vs 3.5%) compared to patients with only skin lesions. Young adults infected in Latin America with\n                      <jats:italic>L<\/jats:italic>\n                      .\n                      <jats:italic>braziliensis<\/jats:italic>\n                      or\n                      <jats:italic>L<\/jats:italic>\n                      .\n                      <jats:italic>guyanensis<\/jats:italic>\n                      complex typically had an ulcer of the lower limbs with mucosal involvement in 5.8% of cases. Typically, infections with\n                      <jats:italic>L<\/jats:italic>\n                      .\n                      <jats:italic>major<\/jats:italic>\n                      and\n                      <jats:italic>L<\/jats:italic>\n                      .\n                      <jats:italic>tropica<\/jats:italic>\n                      acquired in Africa or the Middle East were not associated with mucosal lesions, while infections with\n                      <jats:italic>L<\/jats:italic>\n                      .\n                      <jats:italic>infantum<\/jats:italic>\n                      , acquired in Southern Europe resulted in slowly evolving facial lesions with mucosal involvement in 22% of cases. Local or systemic treatments were used in patients with different clinical presentations but resulted in similarly high cure rates (89% vs 86%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion\/Significance<\/jats:title>\n                    <jats:p>\n                      CL acquired in\n                      <jats:italic>L<\/jats:italic>\n                      .\n                      <jats:italic>infantum<\/jats:italic>\n                      -endemic European and Mediterranean areas displays unexpected high rates of mucosal involvement comparable to those of CL acquired in Latin America, especially in immunocompromised patients. When used as per recommendations, local therapy is associated with high cure rates.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pntd.0009863","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T15:08:37Z","timestamp":1634137717000},"page":"e0009863","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["Clinical diversity and treatment results in Tegumentary Leishmaniasis: A European clinical report in 459 patients"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9129-7799","authenticated-orcid":true,"given":"Romain","family":"Guery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2034-8376","authenticated-orcid":true,"given":"Stephen L.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gundel","family":"Harms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7358-2791","authenticated-orcid":true,"given":"Andreas","family":"Neumayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Van Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Gangneux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Clerinx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3789-0532","authenticated-orcid":true,"given":"Sara Karlsson","family":"S\u00f6birk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6761-8161","authenticated-orcid":true,"given":"Laurence","family":"Lachaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4840-5093","authenticated-orcid":true,"given":"Mark","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldert","family":"Bart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Ravel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3742-7046","authenticated-orcid":true,"given":"Gert","family":"Van der Auwera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2865-8966","authenticated-orcid":true,"given":"Diana N.","family":"Lockwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4010-929X","authenticated-orcid":true,"given":"Pierre","family":"Buffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the LeishMan Network and the French Cutaneous Leishmaniasis Study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,10,13]]},"reference":[{"key":"pntd.0009863.ref001","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis Worldwide and Global Estimates of Its Incidence","volume":"7","author":"J Alvar","year":"2012","journal-title":"PLoS ONE"},{"key":"pntd.0009863.ref002","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1371\/journal.pntd.0000259","article-title":"Marring Leishmaniasis: The Stigmatization and the Impact of Cutaneous Leishmaniasis in Pakistan and Afghanistan","volume":"2","author":"M Kassi","year":"2008","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"pntd.0009863.ref003","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"S Burza","year":"2018","journal-title":"The Lancet"},{"key":"pntd.0009863.ref004","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1473-3099(16)30217-1","article-title":"Global burden of cutaneous leishmaniasis","volume":"17","author":"C Karimkhani","year":"2017","journal-title":"The Lancet Infectious Diseases"},{"key":"pntd.0009863.ref005","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taz055","article-title":"Cutaneous and mucocutaneous leishmaniasis in travellers and migrants: a 20-year GeoSentinel Surveillance Network analysis","volume":"26","author":"AK Boggild","year":"2019","journal-title":"J Travel Med."},{"key":"pntd.0009863.ref006","doi-asserted-by":"crossref","first-page":"e3208","DOI":"10.1371\/journal.pntd.0003208","article-title":"Leishmaniasis in the Middle East: Incidence and Epidemiology","volume":"8","author":"N Salam","year":"2014","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"pntd.0009863.ref007","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/cid\/cit269","article-title":"Travelers with cutaneous leishmaniasis cured without systemic therapy","volume":"57","author":"G Morizot","year":"2013","journal-title":"Clin Infect Dis"},{"key":"pntd.0009863.ref008","doi-asserted-by":"crossref","first-page":"e0006094","DOI":"10.1371\/journal.pntd.0006094","article-title":"Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea","volume":"11","author":"R Guery","year":"2017","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"pntd.0009863.ref009","first-page":"20538","article-title":"LeishMan: harmonising diagnostic and clinical management of leishmaniasis in Europe","volume":"18","author":"J. Blum","year":"2013","journal-title":"Euro Surveill"},{"key":"pntd.0009863.ref010","doi-asserted-by":"crossref","first-page":"e2130","DOI":"10.1371\/journal.pntd.0002130","article-title":"Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis","volume":"7","author":"P Olliaro","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0009863.ref011","first-page":"173","article-title":"[Therapy of leishmaniasis in France: consensus on proposed guidelines]","volume":"40","author":"PA Buffet","year":"2011","journal-title":"Presse Med"},{"key":"pntd.0009863.ref012","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/jtm.12089","article-title":"LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014","volume":"21","author":"J Blum","year":"2014","journal-title":"J Travel Med"},{"key":"pntd.0009863.ref013","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4269\/ajtmh.16-84256","article-title":"Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"96","author":"N Aronson","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0009863.ref014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2016.11.012","article-title":"Leishmania infections: Molecular targets and diagnosis","volume":"57","author":"M Akhoundi","year":"2017","journal-title":"Molecular Aspects of Medicine"},{"key":"pntd.0009863.ref015","author":"Organization WH, Mediterranean RO for the E","year":"2014","journal-title":"Manual for case management of cutaneous leishmaniasis in the WHO Eastern Mediterranean Region."},{"key":"pntd.0009863.ref016","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.inhe.2012.06.004","article-title":"Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis","volume":"4","author":"J Blum","year":"2012","journal-title":"Int Health."},{"key":"pntd.0009863.ref017","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.md.0000076009.64510.b8","article-title":"Localized mucosal leishmaniasis due to Leishmania (Leishmania) infantum: clinical and microbiologic findings in 31 patients","volume":"82","author":"L Aliaga","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"pntd.0009863.ref018","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.4269\/ajtmh.17-0162","article-title":"Case Report: Old World Mucosal Leishmaniasis: Report of Five Imported Cases to the Hospital for Tropical Diseases, London, United Kingdom","volume":"97","author":"TA Patel","year":"2017","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"pntd.0009863.ref019","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4269\/ajtmh.2012.10-0558","article-title":"Epidemiology of Imported Cutaneous Leishmaniasis at the Hospital for Tropical Diseases, London, United Kingdom: Use of Polymerase Chain Reaction to Identify the Species","volume":"86","author":"EC Wall","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0009863.ref020","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.mayocp.2013.07.018","article-title":"International travel by persons with medical comorbidities: understanding risks and providing advice","volume":"88","author":"NS Hochberg","year":"2013","journal-title":"Mayo Clin Proc."},{"key":"pntd.0009863.ref021","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jinf.2011.03.012","article-title":"Mucosal Leishmania infantum leishmaniasis: Specific pattern in a multicentre survey and historical cases","volume":"63","author":"B Faucher","year":"2011","journal-title":"Journal of Infection"},{"key":"pntd.0009863.ref022","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw008","article-title":"Miltefosine for Mucosal and Complicated Cutaneous Old World Leishmaniasis: A Case Series and Review of the Literature","volume":"3","author":"V Mosimann","year":"2016","journal-title":"Open Forum Infect Dis."},{"key":"pntd.0009863.ref023","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.actatropica.2018.03.016","article-title":"Liposomal amphotericin B treatment of Old World cutaneous and mucosal leishmaniasis: A literature review","volume":"182","author":"V Mosimann","year":"2018","journal-title":"Acta Trop"},{"key":"pntd.0009863.ref024","volume-title":"Manual of procedures for leishmaniases surveillance and control in the Americas","author":"Organization PAH","year":"2019"},{"key":"pntd.0009863.ref025","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4269\/ajtmh.12-0736","article-title":"Randomized, double-blinded, phase 2 trial of WR 279,396 (paromomycin and gentamicin) for cutaneous leishmaniasis in Panama","volume":"89","author":"N Sosa","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0009863.ref026","doi-asserted-by":"crossref","first-page":"e0007253","DOI":"10.1371\/journal.pntd.0007253","article-title":"Topical paromomycin for New World cutaneous leishmaniasis","volume":"13","author":"N Sosa","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0009863.ref027","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/cid\/ciy619","article-title":"Topical 15% Paromomycin-Aquaphilic for Bolivian Leishmania braziliensis Cutaneous Leishmaniasis: A Randomized, Placebo-controlled Trial","volume":"68","author":"J Soto","year":"2019","journal-title":"Clin Infect Dis"},{"key":"pntd.0009863.ref028","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3201\/eid2504.180239","article-title":"Mucosal Leishmaniasis in Travelers with Leishmania braziliensis Complex Returning to Israel","volume":"25","author":"M Solomon","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"pntd.0009863.ref029","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJMoa1202657","article-title":"Topical Paromomycin with or without Gentamicin for Cutaneous Leishmaniasis","volume":"368","author":"A Ben Salah","year":"2013","journal-title":"New England Journal of Medicine"},{"key":"pntd.0009863.ref030","doi-asserted-by":"crossref","first-page":"e432","DOI":"10.1371\/journal.pntd.0000432","article-title":"WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study","volume":"3","author":"AB Salah","year":"2009","journal-title":"PLOS Neglected Tropical Diseases"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0009863","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T00:00:00Z","timestamp":1635120000000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009863","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T13:38:31Z","timestamp":1635169111000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009863"}},"subtitle":[],"editor":[{"given":"Hechmi","family":"Louzir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,10,13]]},"references-count":30,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0009863","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,13]]}}}